Literature DB >> 12857531

Algorithm for the pharmacotherapy of anxiety disorders.

Dan J Stein1.   

Abstract

Since the introduction of distinct anxiety disorders in the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, there has been a growing interest in these conditions, leading to a wealth of pharmacotherapy trials. Guidelines for the treatment of anxiety disorders have been developed on the basis of systematic reviews of the literature and expert consensus in areas where data are lacking. Algorithms provide scaffolding for integrating the data on pharmacotherapy and for pointing to gaps in current knowledge. Pharmacotherapy algorithms have the potential advantage of being concise, user-friendly, and evidence-based. However, such algorithms run the risk of oversimplifying complex clinical realities, and are only as good as the data on which they rest. In this article, an algorithm for the pharmacotherapy of anxiety disorders is presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857531     DOI: 10.1007/s11920-003-0057-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  50 in total

1.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

Authors:  I M Anderson
Journal:  J Affect Disord       Date:  2000-04       Impact factor: 4.839

Review 2.  The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.

Authors:  C A Naranjo; D M Knoke
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Authors:  P Alonso; J Pujol; N Cardoner; L Benlloch; J Deus; J M Menchón; A Capdevila; J Vallejo
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 4.  Treatment of anxiety disorders to remission.

Authors:  J C Ballenger
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

5.  Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study.

Authors:  N Grisaru; M Amir; H Cohen; Z Kaplan
Journal:  Biol Psychiatry       Date:  1998-07-01       Impact factor: 13.382

6.  Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.

Authors:  N DeMartinis; M Rynn; K Rickels; L Mandos
Journal:  J Clin Psychiatry       Date:  2000-02       Impact factor: 4.384

Review 7.  Antidepressant plus benzodiazepine for major depression.

Authors:  T A Furukawa; D L Streiner; L T Young
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 8.  A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders.

Authors:  R Castaneda; N Sussman; L Westreich; R Levy; M O'Malley
Journal:  J Clin Psychiatry       Date:  1996-05       Impact factor: 4.384

Review 9.  Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence.

Authors:  M A Posternak; T I Mueller
Journal:  Am J Addict       Date:  2001

10.  The interaction between pharmacotherapy and psychotherapy in the treatment of posttraumatic stress disorder.

Authors:  S M Southwick; R Yehuda
Journal:  Am J Psychother       Date:  1993
View more
  2 in total

Review 1.  Social anxiety disorder : current treatment recommendations.

Authors:  Jacqueline E Muller; Liezl Koen; Soraya Seedat; Dan J Stein
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review.

Authors:  Wicher A Bokma; Guido A A M Wetzer; Jurriaan B Gehrels; Brenda W J H Penninx; Neeltje M Batelaan; Anton L J M van Balkom
Journal:  Depress Anxiety       Date:  2019-06-23       Impact factor: 6.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.